|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/00 | |
| A61K 31/216 | |||
| A61K 31/5375 | |||
| A61P 35/00 | |||
| A61P 35/04 | |||
| A61P 43/00 |
| (11) | Number of the document | 3505184 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18824327.3 |
| Date of filing the European patent application | 2018-06-29 | |
| (97) | Date of publication of the European application | 2019-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2018/024782 |
| Date | 2018-06-29 |
| (87) | Number | WO 2019/004419 |
| Date | 2019-01-03 |
| (30) | Number | Date | Country code |
| 2017128968 | 2017-06-30 | JP |
| (72) |
SAKAMOTO, Atsuhiro, JP
OKAMURA, Tatsuaki, JP
HARADA, Tomohiro, JP
|
| (73) |
ONO Pharmaceutical Co., Ltd.,
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526,
JP
Nippon Medical School Foundation, 1-1-5, Sendagi Bunkyo-ku, Tokyo 113-8602, JP |
| (54) | INHIBITOR OF POSTOPERATIVE CANCER RECURRENCE AND/OR METASTASIS |
| INHIBITOR OF POSTOPERATIVE CANCER RECURRENCE AND/OR METASTASIS |